EyePoint Pharmaceuticals, Inc. - COM NEW (EYPT)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
58.4M
Holdings value Q2 2024
$508M
Value change Q2 2024
-$17.7M
Grand Portfolio weight change Q2 2024
0%
Number of holders
147
Number of buys Q2 2024
12
Number of sells Q2 2024
-13
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 470K $3.74M -$7.01M $7.99 22
2024 Q2 58.4M $508M -$17.7M $8.70 150
2024 Q1 55M $1.14B +$106M $20.67 163
2023 Q4 49.6M $1.15B +$423M $23.11 141
2023 Q3 33.7M $269M +$16.8M $7.99 103
2023 Q2 31.6M $275M +$22.9M $8.70 82
2023 Q1 29.1M $85.6M -$1.21M $2.94 67
2022 Q4 29.4M $103M -$13.4M $3.50 72
2022 Q3 30.1M $238M -$884K $7.91 81
2022 Q2 30.2M $238M -$3.36M $7.87 79
2022 Q1 30.4M $370M +$7.17M $12.15 80
2021 Q4 29.8M $365M +$94.6M $12.24 86
2021 Q3 22.1M $231M +$14.8M $10.42 63
2021 Q2 20.7M $186M +$7.94M $8.99 60
2021 Q1 19.6M $200M +$124M $10.16 58
2020 Q4 7.7M $50.7M +$50.7M $6.58 33